Use of selective serotonin reuptake inhibitors during pregnancy and breastfeeding has both benefits and risks

被引：0
作者：
不详
机构：
来源：
Drugs & Therapy Perspectives | 2006年 / 22卷 / 3期
关键词：
D O I：
10.2165/00042310-200622030-00007
中图分类号：
学科分类号：
摘要：
Depression is common during pregnancy and the postpartum period and may require pharmacotherapy. Selective serotonin reuptake inhibitors (SSRIs) appear to be the safest choice if pharmacotherapy is required, but are not without adverse effects on the infant both during pregnancy and lactation. While congenital malformations seem to be absent with treatment with most SSRIs, adverse events may occur in neonates exposed to SSRIs during the third trimester. There is little evidence that exposure to SSRIs in utero may have a negative impact on neurodevelopment outcomes in infants. © 2006 Adis Data Information BV. All rights reserved.
引用
收藏
页码：22 / 26
页数：4
相关论文
共 26 条
[1]  
Gentile S., SSRIs in pregnancy and lactation: Emphasis on neurodevelopmental outcome, CNS Drugs, 19, 7, pp. 623-633, (2005)
[2]  
Nordeng H., Spigset O., Treatment with selective serotonin reuptake inhibitors in the third trimester of pregnancy: Effects on the infant, Drug Saf, 28, 7, pp. 565-581, (2005)
[3]  
Halbreich U., Prevalence of mood symptoms and depression during pregnancy: Implications for clinical practice and research, CNS Spectr, 9, 3, pp. 177-184, (2004)
[4]  
Gentile S., The safety of newer antidepressants in pregnancy and breastfeeding, Drug Saf, 28, 2, pp. 137-152, (2005)
[5]  
Troutman B., Cutrona C., Nonpsychotic postpartum depression among adolescent mothers, J Abnorm Psychol, 99, pp. 69-78, (1990)
[6]  
Koren G., Matsui D., Einarson A., Et al., Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?, CMAJ, 172, 11, pp. 1457-1459, (2005)
[7]  
Zuckerman B., Amaro H., Bauchner H., Et al., Depressive symptoms during pregnancy: Relationship to poor health behaviors, Am J Obstet Gynecol, 160, pp. 1107-1111, (1989)
[8]  
Ebehard-Gran M., Eskild A., Opjordsmoen S., Treating mood disorders during pregnancy: Safety considerations, Drug Saf, 28, 8, pp. 695-706, (2005)
[9]  
Chambers C.D., Johnson K.A., Dick L.M., Et al., Birth outcomes in pregnant women taking fluoxetine, N Engl J Med, 335, 14, pp. 1010-1015, (1996)
[10]  
Robert E., Treatment depression in pregnancy, N Engl J Med, 335, pp. 1056-1058, (1996)
123